Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 01, 2025 04:30 ET | Source: Research and Markets

Tenosynovitis Market Research Report 2025-2035 | Rising Demand for Tenosynovitis Treatment Amid Increasing Rheumatoid Arthritis Cases

Dublin, Aug. 01, 2025 (GLOBE NEWSWIRE) -- The "Tenosynovitis Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...
July 21, 2025 07:00 ET | Source: NodThera

NodThera Announces Appointment of Dr. Jyothis George as Chief Medical Officer

NodThera Announces Appointment of Dr. Jyothis George as Chief Medical Officer Former Amgen, Novo Nordisk and Boehringer Ingelheim senior leader joins NodThera Leadership TeamWill spearhead clinical...
July 15, 2025 09:00 ET | Source: Evestia Clinical

Evestia Clinical to merge with Atlantic Research Group

Evestia Clinical to merge with Atlantic Research Group
June 24, 2025 05:32 ET | Source: Research and Markets

Vasculitis Market Analysis Report 2025-2035, Competitive Analysis of GlaxoSmithKline, Mitsubishi Tanabe Pharma, Novartis, and Amgen

Dublin, June 24, 2025 (GLOBE NEWSWIRE) -- The "Vasculitis Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's...
June 17, 2025 13:42 ET | Source: BioAegis Therapeutics

BioAegis Therapeutics Receives FDA Fast Track Designation for Lead Product, Recombinant Human Gelsolin, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)

Fast Track status enables expedited regulatory review timelines and supports the development of recombinant human plasma gelsolin (rhu-pGSN), a novel immune modulator for inflammatory diseases. ...
June 17, 2025 07:00 ET | Source: NodThera

NodThera Announces Appointment of Elisabeth Björk as Board Member

NodThera Announces Appointment of Elisabeth Björk as Board Member Former SVP at AstraZeneca R&D brings deep expertise in obesity and cardiometabolic research, portfolio strategy development and...
June 04, 2025 07:00 ET | Source: NodThera

NodThera Charts Obesity Future with First Patients Dosed in Phase 2 RESOLVE-1 Trial of Oral NLRP3 Inflammasome Inhibitor NT-0796

NodThera Charts Obesity Future with First Patients Dosed in Phase 2 RESOLVE-1 Trial of Oral NLRP3 Inflammasome Inhibitor NT-0796 Pioneering small-molecule program, NT-0796, targets chronic...
June 03, 2025 07:00 ET | Source: Transpire Bio

Transpire Bio Enters into Exclusive License Agreement with Suzhou Intragrand Pharma for Investigational PDE4 Inhibitor

Transpire Bio Inc. has signed an exclusive license agreement with Suzhou Intragrand Pharma Co. for an investigational PDE4 inhibitor
June 02, 2025 07:00 ET | Source: Nurix Therapeutics, Inc.

Sanofi Exercises License Extension Option to Nurix’s STAT6 Program

Sanofi Licenses Nurix's STAT6 program
May 13, 2025 04:02 ET | Source: Research and Markets

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA-V) Market Outlook 2025-2035 - ANCA-V Market Gains Momentum with Novel Therapies Like Avacopan and Rituximab Addressing Unmet Needs

Dublin, May 13, 2025 (GLOBE NEWSWIRE) -- The "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Market - A Global and Regional Analysis: Focus on Country and Regional Analysis - Analysis...

Next Page keyboard_arrow_right